New York State Common Retirement Fund Trims Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

New York State Common Retirement Fund lowered its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 69.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,150 shares of the semiconductor company’s stock after selling 22,641 shares during the period. New York State Common Retirement Fund’s holdings in Axcelis Technologies were worth $709,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Pacer Advisors Inc. lifted its position in shares of Axcelis Technologies by 78,037.4% during the 4th quarter. Pacer Advisors Inc. now owns 782,155 shares of the semiconductor company’s stock valued at $54,649,000 after acquiring an additional 781,154 shares during the period. Reinhart Partners LLC. increased its stake in Axcelis Technologies by 50.7% in the 4th quarter. Reinhart Partners LLC. now owns 1,036,112 shares of the semiconductor company’s stock valued at $72,393,000 after purchasing an additional 348,504 shares in the last quarter. Boston Trust Walden Corp boosted its position in Axcelis Technologies by 61.9% during the fourth quarter. Boston Trust Walden Corp now owns 820,116 shares of the semiconductor company’s stock worth $57,302,000 after purchasing an additional 313,689 shares in the last quarter. Royce & Associates LP grew its holdings in Axcelis Technologies by 157.1% in the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company’s stock valued at $28,694,000 after purchasing an additional 167,235 shares during the last quarter. Finally, Weiss Asset Management LP acquired a new stake in Axcelis Technologies in the third quarter valued at $13,874,000. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

Shares of ACLS opened at $54.87 on Tuesday. Axcelis Technologies, Inc. has a 1 year low of $53.67 and a 1 year high of $158.61. The company’s 50 day simple moving average is $67.21 and its 200 day simple moving average is $82.83. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 8.92, a PEG ratio of 4.52 and a beta of 1.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.05 and a current ratio of 5.41.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings results on Monday, February 10th. The semiconductor company reported $1.54 earnings per share for the quarter, topping analysts’ consensus estimates of $1.25 by $0.29. Axcelis Technologies had a return on equity of 21.02% and a net margin of 19.75%. On average, sell-side analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ACLS. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a research note on Wednesday, February 12th. William Blair downgraded shares of Axcelis Technologies from an “outperform” rating to a “market perform” rating in a report on Wednesday, February 12th. Benchmark downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Finally, Craig Hallum lowered their target price on Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, January 15th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Axcelis Technologies presently has an average rating of “Hold” and a consensus price target of $154.00.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.